Precision Biosystems

Precision Biosystems is a private company founded in 2008, headquartered in San Jose, California (with a noted Massachusetts base on its 'About' page), focusing on automating core laboratory workflows. The company's core technology is a patented fluidic control system that enables consistent, reproducible reagent handling for western blot processing, aiming to improve data quality and lab efficiency. Its business model centers on selling instruments and associated consumables to research laboratories, positioning it in the 'Medical Devices' and 'Drug Delivery' sectors with an 'Early Revenue' status. The primary market opportunity lies in displacing manual, skill-dependent techniques in academic, biotech, and pharmaceutical research settings.

Patented fluidic control and distribution system integrated with automated shaking, designed for consistent reagent handling in automated western blot processing and capillary gel electrophoresis.

Competes in the automated western blotting segment against companies like Bio-Rad Laboratories (with the ChemiDoc™ systems and associated automation), Azure Biosystems, and LI-COR Biosciences. In capillary electrophoresis for nucleic acids, competes with Agilent's Fragment Analyzer systems and other niche players. Differentiation is based on a focused value proposition of affordability, antibody recycling, and patented fluidics for consistency.